# Phase 2 Autism Spectrum Disorder trials: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 2 for Autism Spectrum Disorder that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Autism Spectrum Disorder trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/autism-spectrum-disorder

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 10, 2026 | NCT07812233 | Heart Rate Variability Biofeedback for Anxiety in Autistic Youth | Massachusetts General Hospital | Phase 2 | Recruiting | Autism Spectrum Disorder, Anxiety | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812233) |
| June 11, 2026 | NCT07642661 | A Placebo-controlled Trial of Folinic Acid in Children With ASD | Sponsor not shown (see the record) | Phase 2 | Recruiting | Autism Spectrum Disorder | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07642661) |
| June 9, 2026 | NCT07635862 | Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism | Stanford University | Phase 2 | Not yet recruiting | Autism in Children, Autistic Disorder in Children and Adolescents, Autism Spectrum Disorder | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07635862) |
| June 5, 2026 | NCT07630506 | Folinic Acid as a Treatment for Autism Spectrum Disorder in Children | KK Women's and Children's Hospital | Phase 2 | Recruiting | Autism Spectrum Disorder | 184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630506) |
| May 15, 2026 | NCT07589842 | Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Autism Spectrum Disorder | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589842) |
| September 30, 2025 | NCT07199218 | Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism | Bazelet Nehushtan LtD. | Phase 2 | Recruiting | Autism, Autism Spectrum Disorder | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07199218) |
| August 5, 2025 | NCT07105267 | Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum... | Assistance Publique - Hôpitaux de Paris | Phase 2 | Not yet recruiting | Autism Spectrum Disorder, Fecal Microbiota Transplantation (FMT) | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07105267) |
| July 29, 2025 | NCT07091279 | Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism | Sponsor not shown (see the record) | Phase 2 | Recruiting | Autism Spectrum Disorder, Challenging Behaviour, Aggression, Severe Disruptive Behaviour Disorders, Self-injury | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07091279) |
| July 23, 2025 | NCT07079696 | Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Not yet recruiting | Dup15q Syndrome, Autism Spectrum Disorder, Therapy, All-trans Retinoic Acid | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07079696) |
| April 30, 2025 | NCT06951854 | Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder | Neuroventi Inc. | Phase 2 | Recruiting | Autism Spectrum Disorder (ASD | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06951854) |
| March 10, 2025 | NCT06866275 | Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD) | Children's Hospital of Orange County | Phase 2 | Recruiting | Autism Spectrum Disorder (ASD) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06866275) |
| January 3, 2025 | NCT06757504 | Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD | Shanghai Auzone Biological Technology Co., Ltd. | Phase 2 | Recruiting | Autism Spectrum Disorder (ASD) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06757504) |
| October 8, 2024 | NCT06629324 | Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia | Vinmec Research Institute of Stem Cell and Gene Technology | Phase 2 | Recruiting | Autism Spectrum Disorder | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06629324) |
| July 29, 2024 | NCT06526208 | Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults | Southwest Autism Research & Resource Center | Phase 2 | Recruiting | Autism Spectrum Disorder, Anxiety | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06526208) |
| July 15, 2024 | NCT06500637 | TB006 for Autism Spectrum Disorder | Rossignol Medical Center | Phase 2 | Recruiting | Autism Spectrum Disorder | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06500637) |
| October 13, 2023 | NCT06081348 | Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders | Holland Bloorview Kids Rehabilitation Hospital | Phase 2 | Recruiting | Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder, Fragile X Syndrome, Tuberous Sclerosis, 22Q11 Deletion... | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06081348) |
| August 21, 2023 | NCT05999240 | Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder | New York State Psychiatric Institute | Phase 2 | Recruiting | Autism Spectrum Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05999240) |
| May 18, 2023 | NCT05864508 | Interest of Oxytocin as an Adjuvant Treatment of Psycho-educational Measures in Challenging Behaviors in Children With Autism Spectrum... | University Hospital, Toulouse | Phase 2 | Not yet recruiting | Autism Spectrum Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05864508) |
| March 3, 2023 | NCT05754073 | Oxytocin Effects on Bone in Children With Autism Spectrum Disorder | Sponsor not shown (see the record) | Phase 2 | Recruiting | Autism Spectrum Disorder, Bone Health | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05754073) |
| September 21, 2022 | NCT05546554 | Trial of Suvorexant for Sleep in Children With Autism | Stanford University | Phase 2 | Recruiting | Autism, Autism Spectrum Disorder | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05546554) |
| September 14, 2022 | NCT05540574 | Trial of Zolpidem for Sleep in Children With Autism | Stanford University | Phase 2 | Recruiting | Autism, Autism Spectrum Disorder | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05540574) |
| August 15, 2022 | NCT05501678 | Trial of Diphenhydramine for Sleep in Children With Autism | Stanford University | Phase 2 | Recruiting | Autism, Autism Spectrum Disorder | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05501678) |
| February 20, 2020 | NCT04278898 | Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose | Stanford University | Phase 2 | Recruiting | Autism Spectrum Disorder | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04278898) |
| March 7, 2019 | NCT03866668 | A Study of Esomeprazole in Children With Autism | Stanford University | Phase 2 | Recruiting | Autism, Autism Spectrum Disorder | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03866668) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Stanford University | 6 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Shanghai Auzone Biological Technology Co., Ltd. | 1 |
| New York State Psychiatric Institute | 1 |
| Rossignol Medical Center | 1 |
| Southwest Autism Research & Resource Center | 1 |
| Bazelet Nehushtan LtD. | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University Hospital, Toulouse | 1 |
| Children's Hospital of Orange County | 1 |
| Holland Bloorview Kids Rehabilitation Hospital | 1 |
| Neuroventi Inc. | 1 |
| KK Women's and Children's Hospital | 1 |
| Vinmec Research Institute of Stem Cell and Gene Technology | 1 |
| Massachusetts General Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 13 |
| France | 3 |
| China | 2 |
| Israel | 2 |
| Canada | 1 |
| South Korea | 1 |
| Singapore | 1 |
| Vietnam | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dumpling restaurants in the United States](https://specstream.ai/data/businesses/dumpling-restaurants/united-states)
- [Importers in the United States](https://specstream.ai/data/businesses/importers/united-states)
- [Pediatric anesthesiology practices in the United States](https://specstream.ai/data/businesses/pediatric-anesthesiology-practices/united-states)
- [Syrian restaurants in the United States](https://specstream.ai/data/businesses/syrian-restaurants/united-states)
- [B2B domestic trade companies in the United States](https://specstream.ai/data/businesses/b2b-domestic-trade-companies/united-states)
- [Damage restoration companies in the United States](https://specstream.ai/data/businesses/damage-restoration-companies/united-states)
